StemCells completes direct public offering

StemCells Inc. (NASDAQ:STEM), Palo Alto, Calif. Business: Gene/Cell therapy, Neurology Date completed: 11/3/09 Type: Direct public offering Raised: $12.5 million Units: 10 million Price: $1.25 (unit) ...